Performance Measurement

Similar documents
Performance Measurement

Performance Measurement

Performance Measurement

Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Writing Committee. ACP Performance Measurement Committee Members*

Writing Committee. ACP Performance Measurement Committee Members*

Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Prevention and Wellness: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Writing Committee. ACP Performance Measurement Committee Members*

Performance Measurement

Writing Committee. Amir Qaseem, MD, PhD, MHA; Laurel Borowski, MPH; Robert A. Gluckman, MD; Nasseer A. Masoodi, MD; and David W.

Performance measurement in the U.S. health

Diagnosis and Treatment Asthma: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Measure Information Form

Quality Metrics & Immunizations

Colorado State Innovation Model (SIM) Clinical Quality Measures (CQMs) Reporting Schedules

MERIT-BASED INCENTIVE PAYMENT SYSTEM (MIPS) QUALITY CATEGORY

Disclosures. Preventing Heart Failure Re-admissions in Deaths Due to Cardiovascular Disease (United States: ) Heart Failure

Heart Attack Readmissions in Virginia

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

Inpatient Psychiatric Facility Quality Reporting (IPFQR) Program

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

Quality and Fiscal Metrics: What Proves Success?

STATE OPERATIONS MANUAL

Neurology Endorsement Maintenance Phase I

Hypoglycemia and Quality Measurement

HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN

HEALTHCARE REFORM. September 2012

Implementation: Public Hearing: Request for Comments (FDA-2017-N-6502)

Medicare Physician Fee Schedule Final Rule for CY 2018 Appropriate Use Criteria for Advanced Diagnostic Imaging Services Summary

LRE Executive Dashboard Integrated Care Delivery Platform (ICDP)

Opportunities for Developing Measures for Adult Vaccines

Recommendations for Components of Emergency Department Discharge Protocols

SOC s Guide to the 2013 CMS New Core Measures for Stroke

Pulmonary and Critical Care

NATIONAL VOLUNTARY CONSENSUS STANDARDS: PALLIATIVE CARE AND END-OF-LIFE CARE A CONSENSUS REPORT FINAL REPORT

Current Quality Measurement Priorities and Challenges in the Medical Environment

Kathryn Goodwin, Senior Project Manager, and Karen Johnson, Senior Director

The Future of Cardiac Care: Managing Our Patients Together

Diabetes mellitus is a leading cause of morbidity and

Hospice. Hospice Item Set (HIS) Submission Requirements. Quality Reporting Program Provider Training

Guideline Development at the American College of Physicians. American College of Physicians

EHR Developer Code of Conduct Frequently Asked Questions

Tobacco Use: Screening & Cessation Intervention

RE: Draft CMS Quality Measure Development Plan: Supporting the Transition to the Merit-based Incentive Payment System and Alternative Payment Models

Nitin S. Damle, Disclosure of Interests American College of Physicians

Lowering epilepsy-related treatment costs in the era of patient choice and value-based care

NATIONAL QUALITY FORUM

Breakout: Quality and Performance Measure WG

Truth or Consequences: Making Choices that Impact Patient Care C A L G A R Y A P R I L

Leveraging HIT and Health Information Network to Support Performance Measurement and Reporting

Getting to the core of customer satisfaction in skilled nursing and assisted living. Satisfaction Questionnaire & User s Manual

Mapping Palliative Care Need and Supply in California: Methodology

Design, Results, and Implementation of a Whole Person Intervention for Late Life Care Steven Schroeder, MD

Complete Sleep Apnea Care and Diabetes A Study on Total Cost Savings

Evaluation of the NQF Trial Period for Risk Adjustment for Social Risk Factors

DENTAL QUALITY ALLIANCE: 2018 ANNUAL MEASURES REVIEW

APPENDIX 1 State Summary Tables

Conflict of Interest Policy

Measure Up / Pressure Down: Improving Blood Pressure Control in Washington, DC

Submitted to: Re: Comments on CMS Proposals for Patient Condition Groups and Care Episode Groups

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

More than 1.8 million New York State residents have diabetes, 1

This is a two-part measure which is paired with Measure #154: Falls: Risk Assessment.

Arkansas Health Care Payment Improvement Initiative Congestive Heart Failure Algorithm Summary

Memo. CSAC Action Required. Background. Draft Report. October 23, 2018

Readmission Analysis Using 3M Methodology

3309 Risk-Standardized Survival Rate (RSSR) for In-Hospital Cardiac Arrest (American Heart Association)

August 15, Dear Administrator Verma:

Overview of the Tobacco Treatment (TOB) Core Measure Set

NQF-Endorsed Measures for Endocrine Conditions: Cycle 2, 2014

Rehospitalization Data: A Primer for Clinicians Prepared for Project STAAR

Hospice and Palliative Care: Value-Based Care Near the End of Life

Chapter 5: Acute Kidney Injury

Hospice and Palliative Care: Value-Based Care Near the End of Life

A Perspective from the Co-Chairs of the: National Quality Forum Prevention Endorsement Maintenance Steering Committee

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NATIONAL QUALITY FORUM

ASAR. Australian Sonographer Accreditation Registry. Form 1-2. Application guide for entry onto the register of Accredited Student Sonographers

HF QUALITY MEASURES. Hydralazine/nitrate at discharge: Percent of black heart

Essentia Health East Improves Treatment of Tobacco Dependence

Consensus Standards Approval Committee (CSAC)

Reducing 30-day Rehospitalization for Heart Failure: An Attainable Goal?

ZERO SUICIDE DATA ELEMENTS WORKSHEET

Drug Overdose Morbidity and Mortality in Kentucky,

Drivers of Readmissions: Implications for Performance Measurement

TYPE IN THE CHAT. Please type your name, organization, and city/state into the chat.

Troubleshooting Audio

2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

Hospital Transition Management. Barbara Wood, BSN, MBA

HIV / AIDS Quality Measures AMA/NCQA/HIVMA/IDSA/HRSA and NQF Endorsed

Performance Measure Name: TOB-3 Tobacco Use Treatment Provided or Offered at Discharge TOB-3a Tobacco Use Treatment at Discharge

PCMH 2018 Enrollment and Update August 25, 2017

Item Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING. Meeting Date: 7 November Report Author: Report Sponsor:

This paper outlines the engagement activity that took place, and provides key themes from the 57 written responses received.

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

Prevention and Population Health, Spring 2018 Cycle: CDP Report

Patterns of Hospital Admissions and Readmissions Among HIV-Positive Patients in Southwestern Pennsylvania

Southview Medical Center. Community Benefit Plan & Implementation Strategy

Partial Hospitalization Program Program for Evaluating Payment Patterns Electronic Report. User s Guide Sixth Edition. Prepared by

Transcription:

Performance Measurement Preventive Care: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians Writing Committee Amir Qaseem, MD, PhD, MHA; Nick Fitterman, MD (Chair); J. Thomas Cross, MD, MPH (Vice Chair); Steven M. Asch, MD, MPH; Eileen Barrett, MD, MPH; Peter Basch, MD; Robert Centor, MD; Andrew Dunn, MD, MPH; Catherine MacLean, MD, PhD; Matthew E. Nielsen, MD, MS; Robert Pendleton, MD; Sameer D. Saini, MD, MS; Paul Shekelle, MD, MPH, PhD; Sandeep Vijan, MD, MS; and Sarah J. Dinwiddie, RN, MSN on behalf of the Performance Measurement Committee of the American College of Physicians ACP Performance Measurement Committee Members* Nick Fitterman, MD (Chair); J. Thomas Cross, MD, MPH (Vice Chair); Steven M. Asch, MD, MPH; Eileen Barrett, MD, MPH; Peter Basch, MD; Robert Centor, MD; Andrew Dunn, MD, MPH; Eve A. Kerr, MD, MPH; Catherine MacLean, MD, PhD; Mark Metersky, MD; Matthew E. Nielsen, MD, MS; Robert Pendleton, MD; Stephen D. Persell, MD, MPH; Edmondo J. Robinson, MD, MBA; Sameer D. Saini, MD, MS; Paul Shekelle, MD, MPH, PhD; and Sandeep Vijan, MD, MS Corresponding author: A. Qaseem 190 N. Independence Mall West Philadelphia, PA 19106 Email aqaseem@acponline.org * Individuals who served on the Performance Measurement Committee from initiation of the project until its approval

Introduction The United States healthcare system has shifted its efforts to focus on priority areas of valuebased care and to deliver integrated preventive care services at lower costs. In spite of these efforts, intricacies of the current system impede physician s abilities to seamlessly embed screening protocols and preventive care interventions (1). Lack of awareness and appropriate knowledge, adherence issues beyond the physicians control, and unintended consequences of the pressures to comply with a value-based system pose barriers to quality outcomes among primary care physicians and the populations they serve (2-4). While the impact of screening interventions on lifestyle changes is questionable, stakeholders agree that preventive care measures play a significant role in achieving measureable improvements of clinical outcomes (5). Failure to acknowledge the importance of this role needlessly endangers the health of current and future populations (6). The American College of Physicians (ACP) Performance Measurement Committee (PMC) reviewed performance measures related to Preventive Care to assess whether the measures are evidence-based, methodologically sound, and clinically meaningful. Methods Between November 8, 2017 and April 13, 2018 we searched to identify relevant performance measures from the National Quality Forum (NQF), the Centers for Medicare and Medicaid Services Quality Payment Program (QPP) and the National Quality Measures Clearinghouse (NQMC) websites. The inclusion criteria were performance measures endorsed by the National Quality Forum, currently used in the Centers for Medicare and Medicaid Services (CMS) Value- Based Payment programs (VBP) or currently used in federal reporting programs. The PMC identified and reviewed 28 performance measures. To determine the validity of the selected performance measures as indicators of the quality of health care provided by internal medicine physicians, reviewers used a modification of the RAND-UCLA appropriateness method. The committee chair (NF) and immediate past chair (CM) served as moderators for the panel process and did not rate the measures. Results Among the 28 measures* in preventive care measures list, 6 (21%) were rated as valid, 10 (36%) were rated as not valid, and 12 (43%) were rated as uncertain validity. While the measures rated as invalid represent important clinical concepts, lack of support is mainly based on methodological flaws. *Access the full list of recommendations here

Recommendation ACP does not support MIPS #374: Closing the Referral Loop: Receipt of the Specialist Report. Rationale ACP does not support MIPS measure #374: Closing the Referral Loop: Receipt of the Specialist Report. This measure represents an important clinical concept; however, implementation may lead to an unintended consequence of encouraging unnecessary care. Also, we note several suggestions for the developers to consider when they submit the measure to NQF for reendorsement. The specifications are not well defined and should include an evidence-based time interval and some element of risk-adjustment. Additionally, developers do not cite any evidence to form the basis of the measure. Furthermore, the outcome is based on the level of integration of the participating information system rather than on how well the individual clinician tracks the referral. Information can appear to be 100% transmitted in a wellintegrated system, whereas an independent practice network does not generate this data trail as a byproduct of its work. Additionally, it is not necessary for clinicians to close all referral loops. For instance, clinicians may refer a patient to a disease specialist for a condition that resolves prior to their appointment date. Also, depending on the urgency to complete the referral within a given time frame, the patient may not see the specialist within the measurement period. In this case, the referring clinician would fail the measure. Lastly, the burgeoning use of electronic health records (EHRs) will make this measure become far less relevant in the next several years. This is an important health-it measure for improving care coordination; however, there is less evidence that this measure will improve care if it is implemented at the individual clinician level. Measure Specifications MIPS 374: Closing the Referral Loop: Receipt of the Specialist Report Measure Steward: NQF Status: Description: Numerator Denominator Exclusions: Type of Measure: Intended Level of Attribution: Centers for Medicare & Medicaid Services Not NQF Endorsed Percentage of patients with referrals, regardless of age, for which the referring provider receives a report from the provider to whom the patient was referred Number of patients with a referral, for which the referring provider received a report from the provider to whom the patient was referred. Number of patients, regardless of age, who were referred by one provider to another provider, and who had a visit during the measurement period. None Process Individual Clinician

Care Setting: Data Source: Outpatient Electronic Health Records Recommendation ACP supports NQF #2455: Post-Discharge Appointment for Heart Failure Patients. Rationale ACP supports NQF measure #2455: Post-Discharge Appointment for Heart Failure Patients. Patients with a principle diagnosis of heart failure should schedule a follow-up appointment post-hospitalization. This measure is appropriately specified to assess performance at the level of the facility and implementation will counteract the unintended consequences of the readmission measures. Unlike the re-admission measures, this measure will likely decrease length of stay for patients who are appropriately readmitted for acute exacerbations of heart disease. Also, this measure will likely encourage facilities to participate with their referral base. In contrast to other care coordination measures that only require documentation of the referral to fulfill the measure requirements; this measure is appropriately specified to encourage facilities to close the referral loop. We support implementation of this measure over NQF measure #2439: Post-Discharge Appointment for Heart Failure Patients because this measure allows for more flexibility with scheduling the follow-up appointment. Clinicians other than physicians are permitted to manage the follow-up care and the numerator does not specify a 7- day time-frame for scheduling the follow-up appointment. While this measure is a step in the right direction towards reducing preventable readmissions, it may be ineffective as a quality measure. Programs directed at shared savings from lower utilization of hospital services might be more successful in reducing admissions than programs initiated to date (7). Also, we suggest the developers revise the specifications to include an evidence-based time-frame for scheduling follow-up appointments. Furthermore, developers should consider revising the numerator specifications to define what constitutes a home health visit. For example, it is unclear whether a telemedicine visit meets the requirements of the numerator specifications. In addition to revising the specifications to include telemedicine as an appropriate form of home health visit, developers should also define criteria for what constitutes an appropriate visit (e.g., staffed by APP, MD, or DO; includes assessment of weight or telemonitoring, etc.). Measure Specifications NQF 2455: Post-Discharge Appointment for Heart Failure Patients Measure Steward: American Heart Association/American Stroke Association NQF Status: NQF Endorsed, Last Updated Dec 11, 2015 Use in Federal Program: Description: Professional Certification or Recognition program, Get With the Guidelines Heart Failure Recognition program Percentage of patients, regardless of age, discharged from an inpatient

Numerator Denominator Exclusions: Type of Measure: Intended Level of Attribution: Care Setting: Data Source: facility to ambulatory care or home health care with a principal discharge diagnosis of heart failure for whom a follow up appointment was scheduled and documented prior to discharge (as specified). Patients for whom a follow up appointment was scheduled and documented prior to discharge including either: - an office visit for management for heart failure with a physician OR advanced practice nurse OR physician assistant OR - a home health visit for management of heart failure All patients, regardless of age, discharged from an inpatient facility (i.e., hospital inpatient or observation) to ambulatory care (home/self-care) of home health care with a principle discharge diagnosis of heart failure. Denominator exclusions include: Patient was discharged to a health care facility for hospice care, to home for hospice care, or to a rehabilitation facility. Patient left against medical advice. Patient expired. Process Facility Inpatient/Hospital Registry Data Recommendation ACP does not support NQF #2439: Post-Discharge Appointment for Heart Failure Patients because of uncertain validity. Rationale ACP does not support NQF measure #2439: Post-Discharge Appointment for Heart Failure Patients. This measure is appropriately specified to assess performance at the level of the facility and implementation will counteract the unintended consequences of the re-admission measures. Unlike the re-admission measures, this measure will likely decrease length of stay for patients who are appropriately readmitted for acute exacerbations of heart disease. Also, this measure will likely encourage facilities to participate with their referral base. In contrast to other care coordination measures that only require documentation of the referral to fulfill the measure requirements; this measure is appropriately specified to encourage facilities to close the referral loop. While this measure is a step in the right direction towards reducing preventable readmissions, it may be ineffective as a quality measure. Programs directed at shared savings from lower utilization of hospital services might be more successful in reducing admissions than programs initiated to date (7). Furthermore, we note several suggestions for

developers to consider when they submit the measure to NQF for re-endorsement. First, we encourage facilities to distribute referrals equally so as to avoid placing undue burden on a select number of clinicians who manage patients during the recovery period. Second, there is insufficient evidence to identify the most appropriate follow-up location (e.g., PCP office vs. HF clinics). While developers cite clinical guideline recommendations to form the basis of the measure, the evidence on which the recommendations are based includes flawed studies that identify differences in impact depending on where the patient was seen. Without identification of an appropriate follow-up setting, implementation could promote overuse without clear benefit. Third, there is insufficient evidence to support the benefit of follow-up referrals without further intervention on improvements in clinical outcomes. Fourth, the numerator does not specify any scheduling requirements. It is unclear whether scheduling an appointment post-hospitalization satisfies the numerator requirements. If the patient schedules the followup appointment post-hospitalization, facilities may face challenges with obtaining detailed appointment information. Reliability results for data abstraction were fair, substantiating this concern. Fifth, successful follow-up relies on the availability of the ambulatory network. It is unfair to penalize facilities for failures in the ambulatory care network. A quality measure may be more effective if aimed at criteria for hospital admission or availability of outpatient clinics for treatment of heart failure prior to hospitalization. Measure Specifications NQF 2439: Post-Discharge Appointment for Heart Failure Patients Measure Steward: The Joint Commission NQF Status: NQF Endorsed, Last Updated Oct 03, 2017 Use in Federal Program: Description: Numerator Denominator Exclusions: Public reporting, Professional certification or recognition program Patients for whom a follow-up appointment for an office or home health visit for management of heart failure was scheduled within 7 days postdischarge and documented including location, date, and time. Patients for whom a follow-up appointment for an office or home health visit for management of heart failure was scheduled within 7 days postdischarge and documented including location, date, and time. All heart failure patients discharged from a hospital inpatient setting to home or home care. Excluded Populations: Patients who had a left ventricular assistive device (LVAD) or heart transplant procedure during hospital stay (ICD-10-PCS procedure code for LVAD and heart transplant as defined in Appendix A, Table 2.2) Patients less than 18 years of age Patient who have a Length of Stay greater than 120 days Patients with Comfort Measures Only documented

Type of Measure: Intended Level of Attribution: Care Setting: Data Source: Patients enrolled in a Clinical Trial Patients discharged to locations other than home, home care, or law enforcement Patients with a documented Reason for No Post-Discharge Appointment Within 7 Days Patients who left against medical advice (AMA) Process Facility Inpatient/Hospital Electronic Health Records, Paper Medical Records Financial Financial support for the Performance Measurement Committee comes exclusively from the ACP operating budget. Disclosure of Interests and Management of Conflicts: At each meeting and conference call, ACP staff and PMC committee members declared all financial and intellectual interests relevant to health or healthcare. A record of disclosures of interest is kept for each Performance Measurement Committee meeting and conference call and can be viewed at https://www.acponline.org/about-acp/who-we-are/leadership/committeesboards-councils/performance-measurement-committee/performance-measurement-committeedisclosures-of-interest. Drs. Metersky and Persell reported financial relationships with commercial entities and were recused from authorship of this paper. APPROVED BY THE ACP BOARD OF REGENTS ON: July 21, 2018 Members of the PMC: Individuals who served on the Performance Measurement Committee from initiation of the project until its approval: Steven M. Asch, MD, MPH, FACP Eileen D. Barrett, MD, MPH, FACP Peter Basch, MD, MPH, MACP Robert Centor, MD, MACP J. Thomas Cross, Jr., MD, MPH, FACP Andrew Dunn, MD, MPH, FACP Nick Fitterman, MD, FACP

*Eve Askanas Kerr, MD, MPH, FACP Catherine MacLean, MD, PhD, FACP *Mark Metersky, MD, FACP Matthew E. Nielsen, MD, MS Robert Pendleton, MD, FACP *Stephen D. Persell, MD, MPH, FACP *Edmondo J. Robinson, MD, MBA, FACP Sameer Saini, MD, MS Paul Shekelle, MD, MPH, PhD, FACP Sandeep Vijan, MD, MS Author (participated in discussion and voting). *Non-author contributor (participated in discussion but excluded from voting). Requests and inquiries: Amir Qaseem, MD, PhD, MHA, FACP, American College of Physicians, 190. N Independence Mall West, Philadelphia, PA 19106: email, aqaseem@acponline.org

References 1. Agerwala SM, McCance-Katz EF. Integrating Screening, Brief Intervention, and Referral to Treatment (SBIRT) into Clinical Practic Settings: A Brief Review. Journal of Psychoactive Drugs. 2012;44(4): 307-317. doi:10.1080/02791072.2012.720169 2. Chou WC, Tinetti ME, King MB, Irwin K, Fortinsky RH. Perceptions of physicians on the barriers and facilitators to integrating fall risk evaluation and management into practice. J Gen Intern Med. 2006;21:117-22. 3. Fortinsky RH, Iannuzzi-Suchich M, Baker DI, et al. Fall-risk assessment and management in clinical practice: views from healthcare providers. J Am Geriatr Soc. 2004;52(1522-1526). 4. U.S. Census Bureau. Interim Projections By Age, Sex, Race, and Hispanic Origin: 2000 2050. In: U.S. Census Bureau PD, ed. Suitland, MD; 2004. 5. Van Schayck OC, Pinnock H, Ostrem A, Litt J, Tomlins R, Williams S, et al. IPCRG Consensus statement: tackling the smoking epidemic practical guidance for primary care. Prim Care Respir J. 2008;17(3):185-93. 6. World Health Organization. Preventing chronic diseases: a vital investment: WHO global report. 1.Chronic disease therapy 2.Investments 3.Evidence-based medicine 4.Public policy 5.Intersectoral cooperation I. 2005. 7. Epstein AM, Jha AK, Orav EJ. The Relationship between Hospital Admission Rates and Rehospitalizations. New England Journal of Medicine. 2011;365(24):2287-95. 8. IDSA Sepsis Task Force. Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines. Clinical Infectious Diseases. 2018;66(10):1631-5.